A group representing mayors of cities across the country is pushing the federal government to enact a series of major marijuana law reforms.
The U.S. Conference of Mayors is also calling on cities in states that have legalized cannabis to expunge people’s past convictions.
“The looming threat of federal prosecution or shutdown lends uncertainty to states and local governments and legally compliant commercial cannabis business operators, patients and adult-use consumers, and harms state and local efforts to regulate cannabis for the safety and health of its residents,” reads one of the two measures adopted by the mayors group on Monday.
“The United States Conference of Mayors urges the White House, U.S. Department of Justice and the U.S. Drug Enforcement Administration to immediately remove cannabis from the schedule of the CSA to enable U.S. federal banking regulators to permanently authorize financial institutions to provide services to commercial cannabis businesses, and increase the safety of the public.”
The mayors are also asking federal officials to maintain Obama-era guidance that provides some protections to banks that work with cannabis businesses.
And the measure—sponsored by the mayors of Denver, Las Vegas, Los Angeles, San Francisco, Seattle and other cities—presses Congress to pass a series of amendments to federal spending bills that would continue to shield state medical marijuana programs and add new protections for broader recreational laws as well as additional reforms “to address financial services access challenges for commercial cannabis businesses and extend safe and legal access to veterans.”
The other resolution, on expungements, details the racially “discriminatory enforcement” of prohibition and “calls on local governments, where marijuana has been legalized, to act, moving with urgency to vacate misdemeanor marijuana convictions for conduct that is now deemed legal.”
“The decades long and failed war on drugs has devastated communities of color across our nation and incarcerated a disproportionate and unprecedented amount of people from those communities.”
“A drug conviction, even for the misdemeanor offense of possession of marijuana, can have significant negative consequences affecting a person’s employment opportunities, education options, qualification for government benefits and programs, travel, and immigration status,” the measure says. “Vacating these convictions serves as evidence that the criminal justice system acknowledges the racial disproportionality of enforcement of drug laws and is willing to address that injustice.”
“When government policies create injustice, the government has an obligation to correct that injustice.”
The measures were approved by the Conference’s Criminal and Social Justice Committee on Saturday and then adopted on Monday by the full body, which represents mayors leading the 1,408 U.S. cities with populations of 30,000 or more.
In a related development, several major city mayors are joining together to form a new organization to pressure the federal government to modernize its cannabis laws and to “share best practices among local governments to help advance responsible local control over marijuana.”
Mayors are the ones implementing legal marijuana. We know what works & what doesn’t. Teaming up w/ @MarkFarrellSF, @MayorJenny, @LibbySchaaf, @tedwheeler & @mayorheidi in a first-of-its-kind coalition to help cities, states & Congress prepare for legalization #MayorsMJCoalition pic.twitter.com/M6TCORQc5P
— Michael B. Hancock (@MayorHancock) June 11, 2018
The Government for Responsible U.S. Cannabis Policy Coalition will work to “establish a national framework to proactively prepare governments for implementation of legalized marijuana.”
Seattle Mayor Jenny Durkan, who sponsored the expungement resolution, said she was motivated by the unfairness in marijuana enforcement rates.
“Vacating charges for misdemeanor marijuana possession is a necessary step to correct the injustices of what was a failed War on Drugs, which disproportionately affected communities of color in our nation,” she said in a press release. “The unanimous passage of this resolution proves that city leaders recognize the harm that the failed policies had on people who needed opportunity and treatment. I encourage local leaders to act with urgency in their own cities to give their residents – including immigrants and refugees – a clean slate.”
At the #USCM2018, I’m offering a resolution encouraging local governments to vacate charges for misdemeanor marijuana possession – a necessary step to correct the injustices of the failed war on drugs. Thank you to Criminal & Social Justice Committee & @karenaboutgary for passing
— Mayor Jenny Durkan (@MayorJenny) June 9, 2018
The mayors’ action comes just days after the governors of 12 states joined together to push Congress to pass far-reaching marijuana legislation.
A bipartisan group of 14 members of Congress sent a letter to the mayors endorsing their resolution calling for federal reforms.
“Today, more than half of the American population live in states that have adopted cannabis laws. Many of these responsible and reasonable state-approved policies were supported by voters,” they wrote. “According to recent polls, most Americans support the legalization of cannabis. It is evident that a different federal approach to the issue of cannabis is appropriate, necessary, and supported by a majority of the American public.”
“Your resolution recognizes the realities of cannabis and advocates for many of the same policies that we support.”
The mayors group has passed several marijuana-related resolutions at past conferences.
In 2013, for example, it adopted a measure saying that “states and localities should be able to set whatever marijuana policies work best to improve the public safety and health of their communities…without federal interference.”
Marijuana Moment supporters on Patreon can read the full text of the two new cannabis resolutions adopted by mayors, as well as the letter that members of Congress sent endorsing one of the measures, below:
Three Major Cannabis Reform Bills Are Heading To The Texas House Floor
A Texas House committee unanimously approved a bill on Wednesday to expand the state’s medical marijuana program by adding over a dozen health conditions that would qualify patients for participation. And additional cannabis-related legislation is on the horizon, too, with lawmakers in position to potentially vote on marijuana decriminalization and hemp legalization in short order.
Under the medical marijuana bill, patients with cancer, autism, post-traumatic stress disorder, Alzheimer’s, Parkinson’s, Huntington’s disease, amyotrophic lateral sclerosis, Tourette syndrome, Crohn’s, ulcerative colitis, muscular dystrophy and multiple sclerosis would qualify to access cannabis. Patients who experience certain side effects such as severe nausea from conventional therapies would also be able to get medical cannabis.
That would mark a significant expansion of the state’s currently limited medical marijuana system, which only allows patients with intractable epilepsy who’ve exhausted their pharmaceutical options to access cannabis. Finding a specialist doctor to make the recommendation has been another challenge, which further explains why the program has roughly 600 registered medical marijuana patients in a state of about 29 million people.
“Overall, we’re really pleased to see unanimous support for the legislation out of the public health committee,” Heather Fazio, director of Texans for Responsible Marijuana Policy, told Marijuana Moment. “Legislators are taking this issue more seriously now than every before, and they’re responding to their constituents who want to see these laws changed.”
Fazio said she was especially encouraged that the legislation, which currently has more than 50 authors and coauthors, would establish an in-state research panel to study medical cannabis.
All that said, reform advocates aren’t entirely satisfied with the bill as it was amended. While the expansion would be a welcome development, lawmakers scaled back the proposal so that the 0.5 percent THC cap for medical cannabis products under current law would remain in place, whereas the original bill would have lifted it.
Additionally, there are concerns about certain terminology in the bill. Advocates hoped lawmakers would use the word “recommend” instead of “prescribe” when it comes to the doctor’s role in the program because “prescribing” marijuana could jeopardize health professionals given federal restrictions. That said, the legislation does define “prescription” in a way that offers some protections at the state level.
The bill now heads to the House Calendars Committee, where it will await placement on the agenda for a full House floor vote.
Texas might not seem like the most obvious destination for cannabis reform, but state lawmakers have become increasingly interested in tapping into the issue. Earlier this month, three House committees discussed a total of 11 cannabis-related bills—from decriminalizing marijuana to regulating hemp—in a single day.
A decriminalization bill advanced out of the House Criminal Jurisprudence Committee in a 5-2 vote last month. It’s possible that that legislation, which currently sits in the Calendars Committee, could receive a full House floor vote as early as next week. However, lawmakers are looking at multiple decriminalization bills that have been introduced this session and may decide to advance a different version.
Meanwhile, another cannabis bill is already scheduled to be debated in the full House next week. The legislation, introduced by Rep. Tracy King (D), would legalize hemp and its derivatives like CBD. The House Agriculture and Livestock Committee voted unanimously to advance the legislation earlier this month.
New: State Rep. Tracy King's bill which which would establish a hemp growing program in Texas and legalize hemp and hemp-derived products that contain <0.3% THC will get debated Tuesday in the House. #txlege
— Alexandra Samuels (@AlexSamuelsx5) April 18, 2019
“We’re seeing that policymakers are finally catching up with public opinion and where their constituents stand on this important issue that has affected so many live and families and communities over the last nearly a century,” Fazio said. “Thankfully people are having meaningful conversations about how current policies are failing and new ways that we can move forward. ”
Photo courtesy of Mike Latimer.
People Could Use Marijuana In Public Housing Under New Congressional Bill
People living in federally assisted housing would be allowed to use marijuana in compliance with state law under a bill introduced by Rep. Eleanor Holmes Norton (D-DC) on Thursday.
Current law prohibits those who use a federally illicit substance from being admitted into public housing, and landlords are able to evict such individuals. The congresswoman’s legislation is designed to protect people living in public housing or Section 8 housing from being displaced for using cannabis in states that have legalized for medical or adult use.
“Individuals living in federally funded housing should not fear eviction simply for treating their medical conditions or for seeking a substance legal in their state,” Norton said in a press release. “Increasingly, Americans are changing their views on marijuana, state by state, and it is time that Congress caught up with its own constituents.”
“With so many states improving their laws, this issue should have broad bipartisan appeal because it protects states’ rights,” she said.
The bill would also require the head of the Department of Housing and Urban Development (HUD) to enact regulations to restrict smoking marijuana at these facilities in the same way that it does for tobacco.
Norton introduced an earlier version of the Marijuana in Federally Assisted Housing Parity Act last year, but it did not receive a hearing or vote.
At least one HUD official, who oversees New York and New Jersey, has signaled an interest in amending federal law so that people who use cannabis retain the ability to live in federally assisted housing. Regional officer Lynne Patton tweeted last year that “[s]tate & federal law needs to catch up with medicinal marijuana usage & require private landlords to legally permit the same. Period.”
Photo courtesy of WeedPornDaily.
Hundreds Of People Are Sending CBD Comments To The FDA
The Food and Drug Administration (FDA) announced earlier this month that it was accepting public comments on CBD regulations, and more than 400 people have already made their voices heard.
Comments published on Regulations.gov range widely in subject matter, but the main theme running through them is that regulations should be light and companies should be able to lawfully market products containing cannabidiol. Many added that marijuana in general should be legalized, even though the agency did not request that people weigh in on that broader issue.
The comment period was designed to help inform an upcoming public hearing on CBD regulations that the FDA is holding on May 31. Amy Abernethy, principal deputy commission of the FDA, tweeted a link for stakeholders to register for the hearing on Wednesday.
Are there particular safety concerns re: products with cannabis/cannabis-derived compounds? How does the mode of delivery (e.g., ingestion, absorption, inhalation) affect the safety & exposure? Comments/data on important issues like these can help inform FDA reg. oversight.
— Dr. Amy Abernethy (@DrAbernethyFDA) April 17, 2019
We’re seeking input re: FDA’s reg. strategy for existing products, lawful pathways by which appropriate products containing cannabis/cannabis-derived compounds can be marketed & how to make them more predictable/efficient. Register or submit to the docket: https://t.co/xISRzDgN1S pic.twitter.com/maBllYjr3O
— Dr. Amy Abernethy (@DrAbernethyFDA) April 17, 2019
The FDA listed out several questions mostly concerning the safety of cannabis-derived products, how to enact quality control measures and what “validated analytical testing is needed” to ensure that CBD is manufactured in a consistent manner.
David Mangone, director of government affairs at Americans for Safe Access, offered some tips on how to submit effective comments in an earlier interview with Marijuana Moment, and one of the takeaways was that the FDA is primarily interested in receiving scientific evidence that addresses the agency’s specific questions—as opposed to personal anecdotes about CBD use.
Some, like Matthew Lubeck, followed that advice. He commented that CBD should be allowed into the food supply because “the bioavailability and reactiveness within the human body and the cannabinoid system” isn’t ideal when the compound is isolated.
Brent King offered an assessment examining the potential use of CBD as an exit drug from addictive substances such as opioids. He cited a study that showed reduced opioid overdoses in states that have loosened marijuana laws as an example.
“The gateway theory falls victim to the mistaken assumption that correlation alone implies causation,” King said. “Using the same logic, one could argue that drinking milk is a gateway to illicit drug use since most people who use illicit drugs also drank milk as young people.”
Others raised questions about the CBD market as it exists today—unregulated by the FDA as the agency continues to weigh possible options to allow hemp-derived CBD into the food supply or as dietary supplements. An anonymous comment expressed concerns about product consistency across companies that are already selling CBD, arguing that “variance from product to product is confusing” and makes it difficult to “make an informed decisions” about what products to use.
“The public needs protection from unscrupulous companies goals to get rich,” the person wrote.
All that said, most comments did not adhere to Mangone’s or the FDA’s guidelines. The vast majority of comments were anecdotal and individualized. People suffering from conditions such as anxiety, pain, post-traumatic stress disorder and insomnia urged the FDA to loosen restrictions on CBD, describing their own life-changing experience with the product. Several others talked about the health benefits of CBD that they observed in pets.
While that might not be what the agency asked for, that doesn’t change the fact that there is a broad consensus among those who took the time to comment: CBD is safe and has proven medical value, and people should be allowed to freely access it.
It’s not that simple from the FDA’s perspective, however. Former Commissioner Scott Gottlieb has repeatedly stressed that because CBD exists as an FDA-approved drug (Epidiolex) and hasn’t previously been introduced to the food supply, there’s no clear regulatory framework to put it through, even if that was the intention of the 2018 Farm Bill that legalized hemp and its derivatives.
Gottlieb has told members of Congress that additional legislation may be required to provide for the marketing of CBD, or else it may take years before the FDA can identify an alternative regulatory pathway. In the meantime, the FDA is taking a “risk-based” approach to enforcing laws governing CBD marketing that involves cracking down on companies making unsanctioned claims about the health benefits of their CBD products.
Federal requests for public input on cannabis-related policies are nothing new. Thousands offered their perspective on marijuana scheduling under international treaties when the FDA requested feedback on that issue last year. More recently, another federal agency solicited studies from the public on how cannabis can treat symptoms of Alzheimer’s disease.
Photo courtesy of Rick Proctor.